<DOC>
	<DOCNO>NCT00344734</DOCNO>
	<brief_summary>The study test hypothesis nitric oxide availability change congestive heart failure regard regulation renal hemodynamics , renal sodium excretion release vasoactive hormone . The study test hypothesis compare effect systemic nitric oxide inhibition L-NMMA congestive heart failure patient healthy subject renal hemodynamics , blood pressure plasma level vasoactive hormone .</brief_summary>
	<brief_title>Effects Acute L-NMMA Treatment Renal Hemodynamics Vasoactive Hormones Patients With Congestive Heart Failure</brief_title>
	<detailed_description>The purpose study investigate effect systemic treatment Ng-monomethyl-l-arginine congestive heart failure healthy control : - glomerular filtration rate renal plasma flow - blood pressure heart rate - plasma level vasoactive hormone - lithium clearance The study randomize placebo control</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>omega-N-Methylarginine</mesh_term>
	<criteria>Healthy control Age 20 60 year Both men woman Weight 100 kg Normal clinical examination laboratory screen Fertile woman use contraception Informed consent accord regulation local ethic committee Heart failure Both men woman Age 20 75 year Patients heart failure NYHA group IIIII . Heart failure must derive ischaemic heart disease dilate cardiomyopathy . Diagnosis must verify history echocardiography isotope cardiography . ejection fraction &lt; 0.40 Pcreatinin &lt; 250 Âµmol/L Fertile woman use contraception Informed consent accord regulation local ethic committee Healthy control History clinical evidence disease heart blood vessel , kidney , liver pancreas , endocrine organ , lung , neoplastic disease , myocardial infarction cerebrovascular insult evaluate clinical examination laboratory screen Current medication Drugs alcohol abuse Pregnancy Previously within one year receive 0.2 mSV radioactive treatment diagnostic substance Donation blood le 1 month experiment Heart failure Cardiac valvular disease stenosis Significant cardiac arrythmia Myocardial infarction , PTCA bypass surgery le 3 month study Diseases lever , kidney , lung endocrine organ secondary congestive heart failure Arterial hypertension Neoplastic disease Cerebrovascular insult Treatment ACEinhibitors nitrate stop 1 week study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Nitric oxide</keyword>
	<keyword>Renal hemodynamics</keyword>
</DOC>